KLOW

Description

Overview

KLOW is a co-lyophilized multi-peptide reference material combining four independently characterized research peptides — GHK-Cu (copper tripeptide-1), BPC-157 (a synthetic pentadecapeptide), TB-500 (an N-acetylated fragment of thymosin beta-4), and KPV (a C-terminal tripeptide of alpha-MSH) — in a single vial. It is supplied by G Peptide Labs strictly as a laboratory reagent for in-vitro and preclinical investigation. This product is for research use only. It is not a drug, supplement, or cosmetic, and is not intended for human or veterinary use, diagnosis, or the treatment of any condition.

Each of the four constituents is a distinct chemical entity with its own sequence, molecular weight, and literature record. KLOW consolidates them so that laboratories studying overlapping signaling axes — extracellular-matrix turnover, angiogenic patterning, cytoskeletal dynamics, and inflammatory transcription — can work from one lot-controlled reference material rather than four separate reconstitutions.

Research Context

The individual peptides in KLOW have each been examined in independent bodies of preclinical literature, typically in cell culture, isolated-tissue preparations, and animal models. Researchers investigate them for their reported activity in matrix biology and cell-signaling assays:

• GHK-Cu is studied in fibroblast and gene-expression models for its association with collagen, elastin, and glycosaminoglycan-related transcriptional programs.
• BPC-157 is examined in wound-healing, angiogenesis, and nitric-oxide-pathway models in rodents and in-vitro systems.
• TB-500 / thymosin beta-4 is investigated as an actin-sequestering peptide in cell-migration and tissue-repair models across ocular, dermal, and cardiac preparations.
• KPV is studied as an anti-inflammatory tripeptide in murine colitis models and epithelial-cell assays, where researchers investigate NF-kappaB and MAP-kinase signaling.

All descriptions above refer exclusively to published in-vitro and animal-model findings. No human efficacy, safety, or therapeutic outcome is claimed or implied.

Mechanism of Interest

The scientific rationale for co-formulating these four peptides lies in their non-overlapping proposed mechanisms as reported in preclinical work. GHK-Cu is discussed as a copper-carrier tripeptide linked to matrix-remodeling gene expression. BPC-157 is described in animal models in relation to growth-factor and nitric-oxide signaling. TB-500 fragments are characterized biochemically as actin-binding sequences relevant to cell motility in culture. KPV is reported to modulate inflammatory transcription factors at nanomolar concentrations in epithelial models. Investigators use blends of this kind to probe potential additive or independent effects across these pathways in controlled experimental systems.

Specifications

• Composition: four-peptide lyophilized blend — GHK-Cu, BPC-157, TB-500, KPV (per-component mass ratio stated on the batch COA)
• Purity: each component manufactured to a target of not less than 99% by HPLC (see lot-specific COA)
• Form: sterile-filtered, lyophilized white-to-off-white powder
• Identity confirmation: HPLC and mass spectrometry on the constituent peptides
• Grade: research reference material; not sterile-for-injection, not pharmaceutical grade

Handling, Reconstitution and Storage

• Store the sealed lyophilized vial at -20 degrees C, protected from light and moisture; it is stable for extended periods under these conditions.
• For reconstitution in the laboratory, bacteriostatic or sterile water is typically introduced slowly against the vial wall; avoid vigorous agitation, which can shear peptide chains.
• Because GHK-Cu is a copper complex, researchers should account for potential metal-ion interactions when selecting buffers and co-reagents.
• After reconstitution, aliquot and store at -20 degrees C or below to limit freeze-thaw cycles; use validated internal stability data for your assay conditions.
• Handle using appropriate PPE and standard laboratory safety practice. Keep out of reach of unauthorized personnel.

Quality and Verification

Every lot ships with a third-party certificate of analysis (COA). The COA documents identity and purity for the constituent peptides and is the authoritative record for the specific vial in hand. G Peptide Labs is a Canadian research-peptide supplier; orders are dispatched and tracked within Canada. Researchers are encouraged to cross-reference the reported sequences and molecular weights against the primary literature and public chemical databases before designing experiments, and to independently confirm any critical parameter for their own protocols.

Selected Research

Peer-reviewed references provided for scientific context; they describe laboratory and preclinical findings only.

1. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences Pickart L, Margolina A (2018). PMID: 29986520
2. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Frontiers in Pharmacology Seiwerth S, Milavic M, Vukojevic J, Gojkovic S, Krezic I, et al. (2021). PMID: 34267654
3. Animal studies with thymosin beta-4, a multifunctional tissue repair and regeneration peptide. Annals of the New York Academy of Sciences Philp D, Kleinman HK (2010). PMID: 20536453
4. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases Kannengiesser K, Maaser C, Heidemann J, et al. (2008). PMID: 18092346